lilly food and drug administration news - Search News

Lilly weight-loss drug copycats dealt blow

The Washington Post · 18h

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

Fast Company · 18h

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

Detroit News · 1d

Lilly weight-loss drug copycats dealt blow as shortage ends

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs.

22hon MSN

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...

1d

Lilly's weight-loss drug removed from FDA's shortage list

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

1d

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

Daily Reporter22h

Eli Lilly’s weight-loss drugs no longer in shortage, FDA says

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results